Diagnosis and Treatment of Skin and Soft Tissue Infections: Clinical Experience with Ticarcillin Disodium‐Clavulanate Potassium

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

Volumn 11, Issue 2P2, 1991, Pages 90S-98S

  Pankey, George A ^a  

^a OCHSNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLAVULANIC ACID; TICARCILLIN;

ARTICLE; DIABETES MELLITUS; HUMAN; PRIORITY JOURNAL; SKIN INFECTION; SOFT TISSUE INFECTION;

BACTERIOLOGICAL TECHNIQUES; CONNECTIVE TISSUE DISEASES; DIABETES MELLITUS; FOOT DISEASES; HUMAN; SKIN DISEASES, INFECTIOUS; SKIN ULCER; WOUNDS AND INJURIES;

EID: 0025761639     PISSN: 02770008     EISSN: 18759114     Source Type: Journal    
DOI: 10.1002/j.1875-9114.1991.tb02625.x     Document Type: Article

References (43)

1. Outpatient antimicrobial therapy of skin and skin structure infections
2. Infection of the toe webs by gram‐negative bacteria
3. Infection and diabetes mellitus
4. Primary cutaneous infections: pathogenesis and treatment
5. Approach to rashes and infections of the skin and subcutaneous tissues including infected bites and marine infections
6. Infections due to Lancefield group G streptococci
7. Use of sugar and povidone‐iodine to enhance wound healing: five years' experience
8. Mupirocin (pseudomonic acid)—a promising new topical antimicrobial agent
9. Randomized clinical trial of topical mupirocin versus oral erythromycin for impetigo
10. Topical mupirocin vs. oral erythromycin for pyoderma
11. Impetigo contagiosa III. Comparative efficacy of oral erythromycin and topical mupirocin
12. Nosocomial infections surveillance, 1984
13. Diabetic foot and leg ulcers: therapy must be prompt and aggressive
14. Infection of the diabetic foot
15. Diabetic foot infections. Bacteriologic analysis
16. The infected foot of the diabetic patient: quantitative microbiology and analysis of clinical features
17. Lower extremity infections in diabetics
18. The fetid foot: lower‐extremity infections in patients with diabetes mellitus
19. Timentin versus moxalactam in the treatment of skin and soft tissue infections
20. Cefoxitin in the treatment of diabetic patients with lower extremity infection
21. Amdinocillin plus cefoxitin versus cefoxitin alone in the treatment of mixed soft tissue infections (including diabetic foot infection)
22. Imipenem/cilastatin treatment of lower extremity skin and soft tissue infections in diabetics
23. Overview of bacterial infections in the skin and soft tissue and clinical experience with ticarcillin plus clavulanate potassium in their treatment
24. Improved survival of the diabetic foot: the role of the specialised foot clinic
25. The aetiology of diabetic neuropathic foot ulceration
26. The diabetic foot
27. Eikenella corrodens [abstr]
28. Eikenella corrodens osteomyelitis, arthritis, and cellulitis of the hand
29. Mycobacteria other than Mycobacterium tuberculosis: a review of microbiologic and clinical aspects
30. Vibrio vulnificus wound infection treated successfully with oral ciprofloxacin [letter]
31. Pathogens causing nosocomial infections
32. The diagnosis and treatment of gangrenous and crepitant cellulitis
33. Microbiologic evaluation of cutaneous cellulitis in adults
34. Pharmacokinetics and tissue penetration of ticarcillin combined with clavulanic acid
35. Pharmacokinetics and tissue penetration of Timentin: a simultaneous study of serum, urine lymph, suction blister and subcutaneous thread fluid
36. Bactericidal effects of ticarcillin‐clavulanic acid against beta‐lactamase‐producing bacteria in vivo
37. Noncomparative trial of ticarcillin plus clavulanic acid in skin and soft tissue infections
38. Ticarcillin plus clavulanic acid versus moxalactam in the treatment of skin and soft tissue infections
39. Brief report: comparative study of ticarcillin plus clavulanate potassium and moxalactam in the treatment of surgical infection of the soft tissue
40. Safety and efficacy of ticarcillin plus clavulanic acid in the treatment of infections of soft tissue, bone, and joint
41. An evaluation of the safety and tolerance of Timentin